P1253: MAVORIXAFOR DISRUPTS THE CROSS TALK BETWEEN WALDENSTRÖM'S MACROGLOBULINEMIA CELLS AND THE BONE MARROW MICROENVIRONMENT RESULTING IN ENHANCED SENSITIVITY TO B‐CELL TARGETED THERAPIES | Zendy

Monticelli H. | Zendy; Kruitwagen T. | Zendy; Tardelli M. | Zendy; Rebelo T. | Zendy; Maierhofer B. | Zendy; MaierMunsa S. | Zendy; Zmajkovicova K. | Zendy; Taveras A. G. | Zendy; Nguyen C. | Zendy

Open Access

P1253: MAVORIXAFOR DISRUPTS THE CROSS TALK BETWEEN WALDENSTRÖM'S MACROGLOBULINEMIA CELLS AND THE BONE MARROW MICROENVIRONMENT RESULTING IN ENHANCED SENSITIVITY TO B‐CELL TARGETED THERAPIES

Author(s) -

Monticelli H.,

Kruitwagen T.,

Tardelli M.,

Rebelo T.,

Maierhofer B.,

MaierMunsa S.,

Zmajkovicova K.,

Taveras A. G.,

Nguyen C.

Publication year - 2022

Publication title -

hemasphere

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.677

H-Index - 11

ISSN - 2572-9241

DOI - 10.1097/01.hs9.0000847876.35483.fd

Subject(s) - waldenstrom macroglobulinemia , ibrutinib , cancer research , bone marrow , cxcr4 , stromal cell , bruton's tyrosine kinase , progenitor cell , b cell , haematopoiesis , lymphoplasmacytic lymphoma , immunology , medicine , chemistry , stem cell , leukemia , biology , chemokine , chronic lymphocytic leukemia , microbiology and biotechnology , receptor , antibody , lymphoma , inflammation , tyrosine kinase

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research